Exploring the Genetic Associations Between the Use of Statins and Alzheimer's Disease

키워드

참고문헌 (75)

1. Arvanitakis Z, "Diagnosis and management of dementia", JAMA, 322, pp.1589~1599 (2019)
2. Yiannopoulou KG, "Current and future treatments in Alzheimer disease : an update", J Cent Nerv Syst Dis, 12, pp.1179573520907397~ (2020)
3. Mullard A, "Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating", Nat Rev Drug Discov, 20, pp.3~5 (2021)
4. Makin S, "The amyloid hypothesis on trial", Nature, 559, pp.S4~S7 (2018)
5. Aisen PS, "Failure after failure. What next in AD drug development?", J Prev Alzheimers Dis, 6, pp.150~ (2019)
6. Schneider L, "A resurrection of aducanumab for Alzheimer's disease", Lancet Neurol, 19, pp.111~112 (2020)
7. Ramkumar S, "Statin therapy : review of safety and potential side effects", Acta Cardiol Sin, 32, pp.631~639 (2016)
8. Stroes E, "Statins and LDL-cholesterol lowering : an overview", Curr Med Res Opin, 21(Suppl 6), pp.S9~S16 (2005)
9. Nielsen AG, "The impact of statin use on pneumonia risk and outcome : a combined population-based case-control and cohort study", Crit Care, 16, pp.R122~ (2012)
10. Agarwal R, "Effects of statins on renal function", Mayo Clin Proc, 82, pp.1381~1390 (2007)
11. Longo J, "Statins as anticancer agents in the era of precision medicine", Clin Cancer Res, 26, pp.5791~5800 (2020)
12. Zhao W, "The benefits and risks of statin therapy in ischemic stroke : a review of the literature", Neurol India, 67, pp.983~992 (2019)
13. Giannopoulos S, "Statins and vascular dementia : a review", J Alzheimers Dis, 42(Suppl 3), pp.S315~S320 (2014)
14. Torrandell-Haro G, "Statin therapy and risk of Alzheimer's and age-related neurodegenerative diseases", Alzheimers Dement(N Y), 6, pp.e12108~ (2020)
15. Zhang X, "Statins use and risk of dementia: a dose-response meta analysis", Medicine(Baltimore), 97, pp.e11304~ (2018)
16. Chu CS, "Use of statins and the risk of dementia and mild cognitive impairment : a systematic review and meta-analysis", Sci Rep, 8, pp.5804~ (2018)
17. Poly TN, "Association between use of statin and risk of dementia : a meta-analysis of observational studies", Neuroepidemiology, 54, pp.214~226 (2020)
18. McGuinness B, "Statins for the prevention of dementia", Cochrane Database Syst Rev, (2), pp.CD003160~ (2009)
19. Ott BR, "Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials", J Gen Intern Med, 30, pp.348~358 (2015)
20. Sood S, "A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status", Genome Biol, 16, pp.185~ (2015)
21. Chamaria S, "Intracoronary imaging, cholesterol efflux, and transcriptomics after intensive statin treatment in diabetes", Sci Rep, 7, pp.7001~ (2017)
22. Langfelder P, "WGCNA : an R package for weighted correlation network analysis", BMC Bioinformatics, 9, pp.559~ (2008)
23. Smyth GK, "Bioinformatics and computational biology solutions using R and Bioconductor", pp.397~420 (2005), Springer
24. The Gene Ontology Consortium, "The Gene Ontology Resource : 20 years and still GOing strong", Nucleic Acids Res, 47, pp.D330~ (2019)
25. Kanehisa M, "KEGG : Kyoto Encyclopedia of Genes and Genomes", Nucleic Acids Res, 28, pp.27~30 (2000)
26. Liberzon A, "The Molecular Signatures Database(MSigDB)hallmark gene set collection", Cell Syst, 1, pp.417~425 (2015)
27. Frahm KA, "A comparison of the sexually dimorphic dexamethasone transcriptome in mouse cerebral cortical and hypothalamic embryonic neural stem cells", Mol Cell Endocrinol, 471, pp.42~50 (2018)
28. Dobin A, "STAR : ultrafast universal RNA-seq aligner", Bioinformatics, 29, pp.15~21 (2013)
29. Ewels P, "MultiQC : summarize analysis results for multiple tools and samples in a single report", Bioinformatics, 32, pp.3047~3048 (2016)
30. Anders S, "HTSeq--a Python framework to work with high-throughput sequencing data", Bioinformatics, 31, pp.166~169 (2015)
31. Love MI, "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2", Genome Biol, 15, pp.550~ (2014)
32. Dennis G Jr, "DAVID : database for annotation, visualization, and integrated discovery", Genome Biol, 4, pp.P3~ (2003)
33. Subramanian A, "Gene set enrichment analysis : a knowledge-based approach for interpreting genome-wide expression profiles", Proc Natl Acad Sci U S A, 102, pp.15545~15550 (2005)
34. Carson RA, "Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms", PLoS One, 13, pp.e0196387~ (2018)
35. Miners JS, "Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease", J Cereb Blood Flow Metab, 38, pp.103~115 (2018)
36. Mews P, "Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory", Nature, 546, pp.381~386 (2017)
37. Potkin SG, "Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease", PLoS One, 4, pp.e6501~ (2009)
38. Meng G, "Transcriptional dysregulation study reveals a core network involving the genesis for Alzheimer's disease", bioRxiv, ~ (2017)
39. Palinski W, "Immunomodulatory effects of statins : mechanisms and potential impact on arteriosclerosis", J Am Soc Nephrol, 13, pp.1673~1681 (2002)
40. Preman P, "Astrocytes in Alzheimer's disease : pathological significance and molecular pathways", Cells, 10, pp.540~ (2021)
41. Leduc V, "HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study", Mol Psychiatry, 20, pp.867~873 (2015)
42. Vestergaard M, "Cholesterol, lipids, amyloid beta, and Alzheimer's", Curr Alzheimer Res, 7, pp.262~270 (2010)
43. Yamazaki Y, "Apolipoprotein E and Alzheimer disease : pathobiology and targeting strategies", Nat Rev Neurol, 15, pp.501~518 (2019)
44. Barbero-Camps E, "Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion", Autophagy, 14, pp.1129~1154 (2018)
45. Di Scala C, "Interaction of Alzheimer's β-amyloid peptides with cholesterol : mechanistic insights into amyloid pore formation", Biochemistry, 53, pp.4489~4502 (2014)
46. Iadecola C, "Neurovascular regulation in the normal brain and in Alzheimer's disease", Nat Rev Neurosci, 5, pp.347~360 (2004)
47. Barone E, "Statins more than cholesterol lowering agents in Alzheimer disease : their pleiotropic functions as potential therapeutic targets", Biochem Pharmacol, 88, pp.605~616 (2014)
48. Kawase T, "p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis", Oncogene, 27, pp.3797~3810 (2008)
49. Chang JR, "Role of p53 in neurodegenerative diseases", Neurodegener Dis, 9, pp.68~80 (2012)
50. Wang W, "A multi-marker genetic association test based on the Rasch model applied to Alzheimer's disease", PLoS One, 10, pp.e0138223~ (2015)
51. Velho RV, "Site-1 protease and lysosomal homeostasis", Biochim Biophys Acta Mol Cell Res, 1864, pp.2162~2168 (2017)
52. Cai Y, "Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders", Autophagy, 12, pp.225~244 (2016)
53. Tansley GH, "The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of β-amyloid precursor protein", J Lipid Res, 48, pp.1022~1034 (2007)
54. Walker DG, "Gene expression changes by amyloid β peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes", J Leukoc Biol, 79, pp.596~610 (2006)
55. Marquer C, "Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes", Mol Neurodegener, 9, pp.60~ (2014)
56. Yao F, "Identification of blood biomarkers for Alzheimer's disease through computational prediction and experimental validation", Front Neurol, 9, pp.1158~ (2019)
57. Roy ER, "Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease", J Clin Invest, 130, pp.1912~1930 (2020)
58. Shepard PJ, "The SR protein family", Genome Biol, 10, pp.242~ (2009)
59. Boutej H, "Diverging mRNA and protein networks in activated microglia reveal SRSF3 suppresses translation of highly upregulated innate immune transcripts", Cell Reports, 21, pp.3220~3233 (2017)
60. Sakoh-Nakatogawa M, "Localization of Atg3 to autophagy-related membranes and its enhancement by the Atg8-family interacting motif to promote expansion of the membranes", FEBS Lett, 589, pp.744~749 (2015)
61. Ngu M, "Visualization of Atg3 during autophagosome formation in Saccharomyces cerevisiae", J Biol Chem, 290, pp.8146~8153 (2015)
62. Nixon RA, "Autophagy failure in Alzheimer's disease--locating the primary defect", Neurobiol Dis, 43, pp.38~45 (2011)
63. Ding Q, "Ribosome dysfunction is an early event in Alzheimer's disease", J Neurosci, 25, pp.9171~9175 (2005)
64. Grothe MJ, "Molecular properties underlying regional vulnerability to Alzheimer's disease pathology", Brain, 141, pp.2755~2771 (2018)
65. Rabkin SW, "Reduction of protein synthesis and statin-induced cardiomyocyte cell death", Cardiovasc Toxicol, 7, pp.1~9 (2007)
66. Apicco DJ, "Dysregulation of RNA splicing in tauopathies", Cell Reports, 29, pp.4377~4388 (2019)
67. Hinrich AJ, "Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides", EMBO Mol Med, 8, pp.328~345 (2016)
68. Liao JK, "Isoprenoids as mediators of the biological effects of statins", J Clin Invest, 110, pp.285~288 (2002)
69. Ostrowski SM, "Statins reduce amyloid-β production through inhibition of protein isoprenylation", J Biol Chem, 282, pp.26832~26844 (2007)
70. Mielke MM, "Sex and gender differences in Alzheimer's disease dementia", Psychiatr Times, 35, pp.14~17 (2018)
71. Roberts BH, "Gender disparity in statin response : are statins less effective in women?", Clin Lipidol, 8, pp.161~163 (2013)
72. Raparelli V, "Treatment and response to statins : gender-related differences", Curr Med Chem, 24, pp.2628~2638 (2017)
73. Cosacak MI, "Alzheimer's disease, neural stem cells and neurogenesis : cellular phase at single-cell level", Neural Regen Res, 15, pp.824~827 (2020)
74. Morales AV, "Adult neural stem cells : born to last", Front Cell Dev Biol, 7, pp.96~ (2019)
75. Carson RA, "Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms", PLoS One, 13, pp.e0196387~ (2018)

관련 논문AI추천